throbber
Downloaded from
`
`http://mmbr.asm.org/
`
` on October 5, 2015 by guest
`
`MICROBIOLOGICAL REVIEWS, Sept. 1996, p. 512–538
`0146-0749/96/$04.00⫹0
`Copyright 䉷 1996, American Society for Microbiology
`
`Vol. 60, No. 3
`
`Strategies for Achieving High-Level Expression
`of Genes in Escherichia coli†
`SAVVAS C. MAKRIDES*
`Department of Molecular Biology, T Cell Sciences, Inc., Needham,
`Massachusetts 02194
`
`INTRODUCTION .......................................................................................................................................................512
`CONFIGURATION OF EFFICIENT EXPRESSION VECTORS........................................................................513
`TRANSCRIPTIONAL REGULATION.....................................................................................................................513
`Promoters.................................................................................................................................................................513
`Transcriptional Terminators.................................................................................................................................515
`Transcriptional Antiterminators...........................................................................................................................515
`Tightly Regulated Expression Systems ................................................................................................................516
`TRANSLATIONAL REGULATION .........................................................................................................................516
`mRNA Translational Initiation.............................................................................................................................516
`Translational Enhancers........................................................................................................................................517
`mRNA Stability .......................................................................................................................................................517
`Translational Termination ....................................................................................................................................518
`PROTEIN TARGETING............................................................................................................................................518
`Cytoplasmic Expression .........................................................................................................................................518
`Periplasmic Expression..........................................................................................................................................520
`Extracellular Secretion...........................................................................................................................................521
`FUSION PROTEINS..................................................................................................................................................521
`MOLECULAR CHAPERONES ................................................................................................................................522
`CODON USAGE .........................................................................................................................................................524
`PROTEIN DEGRADATION......................................................................................................................................524
`FERMENTATION CONDITIONS ...........................................................................................................................525
`CONCLUSIONS AND FUTURE DIRECTIONS....................................................................................................526
`ACKNOWLEDGMENTS ...........................................................................................................................................527
`REFERENCES ............................................................................................................................................................527
`
`INTRODUCTION
`
`The choice of an expression system for the high-level pro-
`duction of recombinant proteins depends on many factors.
`These include cell growth characteristics, expression levels,
`intracellular and extracellular expression, posttranslational
`modifications, and biological activity of the protein of interest,
`as well as regulatory issues in the production of therapeutic
`proteins (191, 254). In addition, the selection of a particular
`expression system requires a cost breakdown in terms of pro-
`cess, design, and other economic considerations. The relative
`merits of bacterial, yeast, insect, and mammalian expression
`systems have been examined in detail in an excellent review by
`Marino (362). In addition, Datar et al. (121) have analyzed the
`economic issues associated with protein production in bacterial
`and mammalian cells.
`The many advantages of Escherichia coli have ensured that it
`remains a valuable organism for the high-level production of
`recombinant proteins (177a, 197, 254, 362, 406, 426, 510).
`However, in spite of the extensive knowledge on the genetics
`and molecular biology of E. coli, not every gene can be ex-
`pressed efficiently in this organism. This may be due to the
`unique and subtle structural features of the gene sequence, the
`
`* Mailing address: Department of Molecular Biology, T Cell Sci-
`ences, Inc., 119 4th Ave., Needham, MA 02194.
`† This review is dedicated to the memory of William John Steele, an
`inspired scientist, a great man, mentor, and friend, who died on 8
`December 1995. The world is a better place because of him.
`
`stability and translational efficiency of mRNA, the ease of
`protein folding, degradation of the protein by host cell pro-
`teases, major differences in codon usage between the foreign
`gene and native E. coli, and the potential toxicity of the protein
`to the host. Fortunately, some empirical “rules” that can guide
`the design of expression systems and limit the unpredictability
`of this operation in E. coli have emerged. The major drawbacks
`of E. coli as an expression system include the inability to per-
`form many of the posttranslational modifications found in eu-
`karyotic proteins, the lack of a secretion mechanism for the
`efficient release of protein into the culture medium, and the
`limited ability to facilitate extensive disulfide bond formation.
`On the other hand, many eukaryotic proteins retain their full
`biological activity in a nonglycosylated form and therefore can
`be produced in E. coli (see, e.g., references 170, 342, and 486).
`In addition, some progress has been made in the areas of
`extracellular secretion and disulfide bond formation, and these
`will be examined.
`The objectives of this review are to integrate the extensive
`published literature on gene expression in E. coli, to focus on
`expression systems and experimental approaches useful for the
`overproduction of proteins, and to review recent progress in
`this field. Areas that have been covered in detail in recent
`reviews are included in abbreviated form in order to present
`their key conclusions and to serve as a source for further
`reading. As a matter of definition, the terms “periplasmic ex-
`pression” and “extracellular secretion” will be used to refer to
`the targeting of protein to the periplasm and the culture me-
`dium, respectively, to avoid confusion.
`
`512
`
`BEQ 1023
`Page 1
`
`

`
`VOL. 60, 1996
`
`HIGH-LEVEL GENE EXPRESSION IN E. COLI
`
`513
`
`Downloaded from
`
`http://mmbr.asm.org/
`
` on October 5, 2015 by guest
`
`FIG. 1. Schematic presentation of the salient features and sequence elements of a prokaryotic expression vector. Shown as an example is the hybrid tac promoter
`(P) consisting of the ⫺35 and ⫺10 sequences, which are separated by a 17-base spacer. The arrow indicates the direction of transcription. The RBS consists of the SD
`sequence followed by an A⫹T-rich translational spacer that has an optimal length of approximately 8 bases. The SD sequence interacts with the 3⬘ end of the 16S rRNA
`during translational initiation, as shown. The three start codons are shown, along with the frequency of their usage in E. coli. Among the three stop codons, UAA
`followed by U is the most efficient translational termination sequence in E. coli. The repressor is encoded by a regulatory gene (R), which may be present on the vector
`itself or may be integrated in the host chromosome, and it modulates the activity of the promoter. The transcription terminator (TT) serves to stabilize the mRNA and
`the vector, as explained in the text. In addition, an antibiotic resistance gene, e.g., for tetracycline, facilitates phenotypic selection of the vector, and the origin of
`replication (Ori) determines the vector copy number. The various features are not drawn to scale.
`
`CONFIGURATION OF EFFICIENT
`EXPRESSION VECTORS
`The construction of an expression plasmid requires several
`elements whose configuration must be carefully considered to
`ensure the highest levels of protein synthesis (22, 64, 120, 142,
`355, 538, 612). The essential architecture of an E. coli expres-
`sion vector is shown in Fig. 1. The promoter is positioned
`approximately 10 to 100 bp upstream of the ribosome-binding
`site (RBS) and is under the control of a regulatory gene, which
`may be present on the vector itself or integrated in the host
`chromosome. Promoters of E. coli consist of a hexanucleotide
`sequence located approximately 35 bp upstream of the tran-
`scription initiation base (⫺35 region) separated by a short
`spacer from another hexanucleotide sequence (⫺10 region)
`(174, 232, 236, 344, 465). There are many promoters available
`for gene expression in E. coli, including those derived from
`gram-positive bacteria and bacteriophages (Table 1). A useful
`promoter exhibits several desirable features: it is strong, it has
`a low basal expression level (i.e., it is tightly regulated), it is
`easily transferable to other E. coli strains to facilitate testing of
`a large number of strains for protein yields, and its induction is
`simple and cost-effective (612).
`Downstream of the promoter is the RBS, which spans a
`region of approximately 54 nucleotides bound by positions ⫺35
`(⫾2) and ⫹19 to ⫹22 of the mRNA coding sequence (269).
`The Shine-Dalgarno (SD) site (514, 515) interacts with the 3⬘
`end of 16S rRNA during translation initiation (133, 532). The
`distance between the SD site and the start codon ranges from
`5 to 13 bases (93), and the sequence of this region should
`eliminate the potential of secondary-structure formation in the
`mRNA transcript, which can reduce the efficiency of transla-
`tion initiation (198, 229). Both 5⬘ and 3⬘ regions of the RBS
`exhibit a bias toward a high adenine content (140, 499, 502).
`The transcription terminator is located downstream of the
`coding sequence and serves both as a signal to terminate tran-
`scription (465) and as a protective element composed of stem-
`loop structures, protecting the mRNA from exonucleolytic
`degradation and extending the mRNA half-life (35, 37, 147,
`227, 249, 597).
`In addition to the above elements that have a direct impact
`on the efficiency of gene expression, vectors contain a gene that
`confers antibiotic resistance on the host to aid in plasmid
`selection and propagation. Ampicillin is commonly used for
`this purpose; however, for the production of human therapeu-
`
`tic proteins, other antibiotic resistance markers are preferable
`to avoid the potential of human allergic reactions (42). Finally,
`the copy number of plasmids is determined by the origin of
`replication. In specific cases, the use of runaway replicons
`results in massive amplification of plasmid copy number con-
`comitant with higher yields of plasmid-encoded protein (387,
`415). In other cases, however, there appeared to be no advan-
`tage in using higher-copy-number plasmids over pBR322-
`based vectors (612). Furthermore, Vasquez et al. (572) re-
`ported that
`increasing the copy number of
`the plasmid
`decreased the production of trypsin in E. coli and Minas and
`Bailey (379) found that the presence of strong promoters on
`high-copy-number plasmids severely impaired cell viability.
`
`TRANSCRIPTIONAL REGULATION
`
`Promoters
`A promoter for use in E. coli (Table 1) should have certain
`characteristics to render it suitable for high-level protein syn-
`thesis (207, 612). First, it must be strong, resulting in the
`accumulation of protein making up 10 to 30% or more of the
`total cellular protein.
`Second, it should exhibit a minimal level of basal transcrip-
`tional activity. Large-scale gene expression preferably employs
`cell growth to high density and minimal promoter activity,
`followed by induction or derepression of the promoter. The
`tight regulation of a promoter is essential for the synthesis of
`proteins which may be detrimental to the host cell (see, e.g.,
`references 68, 137, 544, 563, and 599). For example, the toxic
`rotavirus VP7 protein effectively kills cells and must be pro-
`duced under tightly regulated conditions (592). However, in
`some cases, promoter stringency is inconsequential, because
`even the smallest amount of gene product drastically curtails
`bacterial survival because of its severe toxicity (615). For ex-
`ample, molecules that inactivate ribosomes or destroy the
`membrane potential would be lethal. Toxicity to the host is not
`restricted to foreign genes but may also result from the over-
`expression of certain native genes, such as the traT gene, which
`encodes an outer membrane lipoprotein (423), the EcoRI re-
`striction endonuclease in the absence of the corresponding
`protective EcoRI modification methylase (423), and the lon
`gene (558). Furthermore, incompletely repressed expression
`systems can cause plasmid instability, a decrease in cell growth
`rate, and loss of recombinant protein production (40, 98, 374).
`
`BEQ 1023
`Page 2
`
`

`
`514
`
`MAKRIDES
`
`MICROBIOL. REV.
`
`TABLE 1. Promoters used for the high-level expression of genes in E. coli
`
`Promoter (source)
`
`Regulation
`
`Induction
`
`Reference(s)
`
`lac (E. coli)
`
`trp (E. coli)
`lpp (E. coli)
`phoA (E. coli)
`recA (E. coli)
`araBAD (E. coli)
`proU (E. coli)
`cst-1 (E. coli)
`tetA (E. coli)
`cadA (E. coli)
`nar (E. coli)
`tac, hybrid (E. coli)
`
`trc, hybrid (E. coli)
`
`lacI, lacIq
`lacI(Ts),a lacIq(Ts)a
`lacI(Ts)b
`
`phoB (positive), phoR (negative)
`lexA
`araC
`
`cadR
`fnr (FNR, NARL)
`lacI, lacIq
`lacId
`lacI, lacIq
`lacI(Ts),a lacIq(Ts)a
`lacI
`lacI, lacIq
`
`␭cIts857
`
`␭cIts857
`␭cIts857
`lacIq
`␭cIts857, lacIq
`lacIq
`lacIq, lacI
`
`lacIq
`
`Downloaded from
`
`http://mmbr.asm.org/
`
` on October 5, 2015 by guest
`
`IPTG
`Thermal
`Thermal
`Trp starvation, indole acrylic acid
`IPTG, lactosec
`Phosphate starvation
`Nalidixic acid
`L-Arabinose
`Osmolarity
`Glucose starvation
`Tetracycline
`pH
`Anaerobic conditions, nitrate ion
`IPTG
`Thermal
`IPTG
`Thermal
`IPTG
`IPTG
`
`Thermal
`Reduced temperature (⬍20⬚C)
`Reduced temperature (⬍20⬚C)
`Thermal
`Thermal
`IPTG
`Thermal, IPTG
`IPTG
`IPTG
`T4 infection
`IPTG
`Oxygen, cAMP-CAPe
`
`17, 18, 221, 460, 610
`234
`604
`365, 470, 549, 612
`128a, 142, 185, 275, 401
`84, 274, 291, 306, 382, 562
`145, 260, 428, 516
`554
`247
`564
`125, 523
`102, 480, 561
`335
`7, 123, 471
`603
`65
`4, 9
`261, 263
`186
`366
`43, 80, 129, 130, 240, 454
`187, 433
`187, 206, 433, 551
`150, 493
`537, 548
`141, 190, 239
`375
`190, 605
`71, 390
`143, 210
`605
`304, 305
`1,256, 349
`
`lpp-lac, hybrid (E. coli)
`Psyn, synthetic (E. coli)
`Starvation promoters (E. coli)
`pL (␭)
`pL-9G-50, mutant (␭)
`cspA (E. coli)
`pR, pL, tandem (␭)
`T7 (T7)
`T7-lac operator (T7)
`␭pL, pT7, tandem (␭, T7)
`T3-lac operator (T3)
`T5-lac operator (T5)
`T4 gene 32 (T4)
`nprM-lac operator (Bacillus spp.)
`VHb (Vitreoscilla spp.)
`Protein A (Staphylococcus aureus)
`a lacI gene with single mutation, Gly-187 3 Ser (72).
`b lacI gene with three mutations, Ala-241 3 Thr, Gly-265 3 Asp, and Ser-300 3 Asn (604).
`c The constitutive lpp promoter (Plpp) was converted into an inducible promoter by insertion of the lacUV5 promoter/operator region downstream of Plpp. Thus,
`expression occurs only in the presence of a lac inducer (142).
`d Wild-type lacI gene.
`e cAMP-CAP, cyclic AMP-catabolite activator protein.
`
`Lanzer and Bujard carried out extensive studies on the com-
`monly used lac-based promoter-operator systems and demon-
`strated up to 70-fold differences in the level of repression when
`the operator was placed in different positions within the pro-
`moter sequence (328). Thus, when the 17-bp operator was
`placed between the ⫺10 and ⫺35 hexameric regions, a 50- to
`70-fold-greater repression was caused than when the operator
`was placed either upstream of the ⫺35 region or downstream
`of the ⫺10 site (328).
`A third important characteristic of a promoter is its induc-
`ibility in a simple and cost-effective manner. The most widely
`used promoters for large-scale protein production use thermal
`induction (␭ pL) or chemical inducers (trp) (Table 1). The
`isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible hybrid
`promoters tac (123) or trc (65) are powerful and widely used
`for basic research. However, the use of IPTG for the large-
`scale production of human therapeutic proteins is undesirable
`because of its toxicity (159) and cost. These drawbacks of IPTG
`have until now precluded the use of the tac or trc promoter
`from the production of human therapeutic proteins and ren-
`dered the large-scale expression of proteins for basic research
`prohibitively expensive. The availability of a mutant lacI(Ts)
`gene that encodes a thermosensitive lac repressor (72) now
`permits the thermal induction of these promoters (4, 9, 234). In
`addition, the new vectors exhibit tight regulation of the trc
`
`promoter at 30⬚C (9). Two different lac repressor mutants that
`are thermosensitive (586, 604) as well as IPTG inducible (586)
`have recently been described. Although the wild-type lacI gene
`can be thermally induced (602, 603), this system is not tightly
`regulated and cannot be used in lacIq strains, since a temper-
`ature shift does not override the tight repression caused by the
`overproduction of the lac repressor (603). Thus, this system is
`limited to the production of some proteins that are not detri-
`mental to the host cell.
`Cold-responsive promoters, although much less extensively
`studied than many of the other promoters included here, have
`been shown to facilitate efficient gene expression at reduced
`temperatures. The activity of the phage ␭ pL promoter was
`highest at 20⬚C and declined as the temperature was raised
`(187). This cold response of the pL promoter is positively
`regulated by the E. coli integration host factor, a sequence-
`specific, multifunctional protein that binds and bends DNA
`(164, 165, 188). The promoter of the major cold shock gene
`cspA (206, 551) was similarly demonstrated to be active at
`reduced temperatures (187). Molecular dissection of the cspA
`and pL promoters led to the identification of specific DNA
`regions involved in the enhancement of transcription at lower
`temperatures; this has allowed the development of pL deriva-
`tives that are highly active at temperatures below 20⬚C (433).
`The rationale behind the use of cold-responsive promoters for
`
`BEQ 1023
`Page 3
`
`

`
`Downloaded from
`
`http://mmbr.asm.org/
`
` on October 5, 2015 by guest
`
`VOL. 60, 1996
`
`HIGH-LEVEL GENE EXPRESSION IN E. COLI
`
`515
`
`gene expression is based on the proposition that the rate of
`protein folding will be only slightly affected at about 15 to 20⬚C,
`whereas the rates of transcription and translation, being bio-
`chemical reactions, will be substantially decreased. This, in
`turn, will provide sufficient time for protein refolding, yielding
`active proteins and avoiding the formation of inactive protein
`aggregates, i.e., inclusion bodies, without reducing the final
`yield of the target protein (433). It would be interesting to
`compare the transcriptional activities of other promoters de-
`rived from cold shock genes (288, 402).
`Other promoters that have been characterized recently (Ta-
`ble 1) possess attractive features and should provide additional
`options for high-level gene expression systems. For example,
`the pH promoter (102, 561) is very strong: recombinant pro-
`teins are produced at levels of up to 40 to 50% of the total
`cellular protein (480). This expression level, however, will
`probably vary for different genes, because protein synthesis
`depends on translational efficiency as well as promoter
`strength.
`E. coli promoters are usually considered in terms of a core
`region composed of the ⫺10 and ⫺35 hexameric sequences
`including a 15- to 19-bp spacer between the two hexamers
`(344). However, it has been proposed that elements outside
`the core region stimulate promoter activity (134). Many studies
`have demonstrated that sequences upstream of the core pro-
`moter increase the rate of transcription initiation in vivo (172,
`213, 264, 290, 618). Gourse and colleagues have shown that a
`DNA sequence, the UP element, located upstream of the ⫺35
`region of the E. coli rRNA promoter rrnB P1, stimulates tran-
`scription by a factor of 30 in vitro and in vivo (290, 453, 468).
`The UP element functions as an independent promoter mod-
`ule because when it is fused to other promoters such as lacUV5,
`it stimulates transcription (453, 468). Upstream activation in E.
`coli and other organisms has been reviewed in detail (110). The
`ability of the UP element to act as a transcriptional enhancer
`when fused to heterologous promoters may be of general util-
`ity in high-level expression systems.
`Although the extraordinary strength of the rRNA promoters
`P1 and P2 is well documented (173, 414), these promoters have
`not been exploited for the high-level production of proteins in
`E. coli, mainly because their regulation is more difficult. The in
`vivo synthesis of rRNA is subject to growth rate control (213),
`and P1 and P2 are active during periods of rapid cell growth
`and are downregulated when cells are in the stationary phase
`of growth. Therefore, the rRNA promoters would be contin-
`uously active or “leaky” during the preinduction phase. In vivo
`P2 is the weaker, less inducible promoter in rapidly growing
`cells. However, when uncoupled from P1, the P2 promoter
`shows increased activity (up to 70% of that of P1) and becomes
`sensitive to the stringent response, indicating that in its native
`tandem context, P2 is partially occluded (173, 289). Brosius
`and Holy (66) inserted the lac operator sequence downstream
`of the rrnB rRNA P2 promoter and achieved repression of P2
`in strains harboring the lacIq gene. Transcriptional activity was
`measured by the production of chloramphenicol acetyltrans-
`ferase and by the expression of the 4.5S RNA. However, the P2
`construction was only half as active as the tac promoter, and
`furthermore, when the rrnB P1 promoter was placed upstream
`of the P2 promoter, transcriptional repression was incomplete
`(66).
`It is tempting to speculate that rRNA promoters could be
`tightly regulated by using the concept of inverted promoters
`(see the section on tightly regulated expression systems, be-
`low). Thus, a rRNA promoter could be cloned upstream of the
`gene of interest but in the opposite transcriptional direction.
`The use of ␭ integration sites and a regulated ␭ integrase
`
`would facilitate the inversion of the promoter for induction,
`and the presence of strong transcription terminators upstream
`of the highly active promoter would prevent destabilization of
`the vector during the preinduction phase.
`
`Transcriptional Terminators
`In prokaryotes, transcription termination is effected by two
`different types of mechanisms: Rho-dependent transcription
`termination depends on the hexameric protein rho, which
`causes the release of the nascent RNA transcript from the
`template. In contrast, rho-independent termination depends
`on signals encoded in the template, specifically, a region of
`dyad symmetry that encodes a hairpin or stem-loop structure in
`the nascent RNA and a second region that is rich in dA and dT
`and is located 4 to 9 bp distal to the dyadic sequence (83, 122,
`439, 455, 456, 465, 594, 609). Although often overlooked in the
`construction of expression plasmids, efficient transcription ter-
`minators are indispensable elements of expression vectors, be-
`cause they serve several important functions. Transcription
`through a promoter may inhibit its function, a phenomenon
`known as promoter occlusion (5). This interference can be
`prevented by the proper placement of a transcription termina-
`tor downstream of the coding sequence to prevent continued
`transcription through another promoter. Similarly, a transcrip-
`tion terminator placed upstream of the promoter that drives
`expression of the gene of interest minimizes background tran-
`scription (413). It is also known that transcription from strong
`promoters can destabilize plasmids as a result of overproduc-
`tion of the ROP protein involved in the control of plasmid copy
`number as a result of transcriptional readthrough into the
`replication region (539). In addition, transcription terminators
`enhance mRNA stability (237, 404, 597) and can substantially
`increase the level of protein production (237, 572). Particularly
`effective are the two tandem transcription terminators T1 and
`T2, derived from the rrnB rRNA operon of E. coli (67), but
`many other sequences are also quite effective.
`
`Transcriptional Antiterminators
`In bacteria, many operons involved in amino acid biosynthe-
`sis contain transcriptional attenuators at the 5⬘ end of the first
`structural gene. The attenuators are regulated by the amino
`acid products of the particular operon. Thus, the availability of
`the cognate charged tRNA leads to the formation of a second-
`ary structure in the nascent transcript followed by ribosome
`stalling. In the absence of the cognate charged tRNA, an an-
`titerminator structure which prevents formation of the RNA
`hairpin in the terminator and prevents transcriptional termi-
`nation is formed (325). The antiterminator element that en-
`ables RNA polymerase to override a rho-dependent termina-
`tor in the ribosomal RNA operons has been identified and is
`referred to as boxA (41, 341). Transcriptional antitermination
`is a remarkably complex process that involves many known and
`as yet unidentified host factors. This topic has been covered in
`great detail in two excellent recent reviews (110, 456). Here, we
`will briefly consider the use of antitermination elements that
`are useful in the expression of heterologous genes in E. coli.
`One of the more powerful and widely used expression sys-
`tems in E. coli makes use of the phage T7 late promoter (537,
`548). The activity of this system depends on a transcription unit
`that supplies the T7 RNA polymerase, whose tight repression
`is essential to avoid leakiness of the T7 promoter. Several
`approaches have been used to regulate the expression of the
`T7 polymerase, and each has its own unique disadvantages
`(374). Mertens et al. (374) addressed this problem by con-
`structing a reversibly attenuated T7 RNA polymerase expres-
`
`BEQ 1023
`Page 4
`
`

`
`Downloaded from
`
`http://mmbr.asm.org/
`
` on October 5, 2015 by guest
`
`516
`
`MAKRIDES
`
`MICROBIOL. REV.
`
`sion cassette based on ␭ pL regulation. Thus, the basal expres-
`sion level of the T7 polymerase was attenuated by inserting
`three tandemly arranged transcription terminators between
`the promoter and the gene encoding the T7 polymerase. For
`induction, the phage ␭-derived nutL-dependent antitermina-
`tion function was also incorporated to override the transcrip-
`tion block. Alternatively, an IPTG-inducible promoter was
`similarly used, allowing conditional reversion of attenuation
`upon induction (374).
`The transcriptional antitermination region from the E. coli
`rrnB rRNA operon has been used in the expression vector
`pSE420, which utilizes the trc promoter (64). The rationale in
`this case was to facilitate transcription through areas of severe
`secondary structure, thus reducing the possibility of premature
`transcription termination by the host RNA polymerase. In this
`case, however, the presence of the rrnB antiterminator is ap-
`parently ineffective (64a).
`
`Tightly Regulated Expression Systems
`The advantages of tightly regulated promoters (see the sec-
`tion on promoters, above) have led to the design of many
`ingenious and highly repressible expression systems that are
`particularly useful for the expression of genes whose products
`are detrimental to host growth. The various approaches in-
`clude the use of a “plating” method (544), the increase of the
`repressor-to-operator ratio (9, 391),
`induction by infection
`with mutant phage (68, 137), attenuation of promoter strength
`on high-copy-number vectors (587), the use of transcription
`terminators (374, 375, 413) in combination with antitermina-
`tors (374), the use of an inducible promoter within a copy-
`number-controllable plasmid (558), “cross-regulation” systems
`(97, 98), cotransformation of plasmids utilizing the SP6 RNA
`polymerase (473), and the use of antisense RNA complemen-
`tary to the mRNA of the cloned gene (423). Finally, one
`elegant approach involves the principle of invertible promot-
`ers: the promoter, flanked by two ␭ integration sites, faces in
`the direction opposite that of the gene to be expressed and is
`inverted only by inducing site-specific genetic recombination
`mediated by the ␭ integrase (16, 21, 235, 441, 599).
`The above systems have advantages as well as disadvantages,
`depending on their intended use. Thus, methods that rely on
`solid media cannot easily be used for large-scale expression.
`High-level repressor systems often cause a substantial decrease
`in protein yield (9, 531), thus necessitating optimization of the
`repressor-to-operator ratio (234). Induction mediated by ␭
`phage adds further complexity to the system. The use of in-
`verted promoter circuits involves complex vector construc-
`tions. Although most of the above systems have not yet been
`used for the high-level production of proteins on a large scale,
`they nevertheless provide important tools for the armamentar-
`ium of gene expression.
`
`TRANSLATIONAL REGULATION
`
`mRNA Translational Initiation
`The extensive knowledge of the transcriptional process has
`allowed the use of prokaryotic promoters in cassette fashion,
`unaffected by the surrounding nucleotide context (232, 236,
`317, 344). However, the determinants of protein synthesis ini-
`tiation have been more difficult to decipher; this is not surpris-
`ing, considering the complexity of this process (224, 579). It is
`now clear that the wide range of efficiencies in the translation
`of different mRNAs is predominantly due to the unique struc-
`tural features at the 5⬘ end of each mRNA species. Thus, in
`
`contrast to the portable promoters, no universal sequence for
`the efficient initiation of translation has been devised. How-
`ever, progress in this aspect of gene expression in E. coli has
`been strong, and general “guidelines” have emerged (131, 133,
`196, 198, 218, 368, 369, 458, 579, 590).
`The translational initiation region of most sequenced E. coli
`genes (91%) contains the initiation codon AUG. GUG is used
`by about 8% of the genes, and UUG is rarely used as a start
`site (1%) (218, 224, 535). In one case, AUU is used as the start
`codon for infC (75). This codon is required for the autogenous
`regulation of infC. The translational efficiency of the initiation
`codons in E. coli has been examined. AUG is the preferred
`codon by two- to threefold, and GUG is only slightly better
`than UUG (458, 573).
`Shine and Dalgarno (514, 515) identified a sequence in the
`RBS of bacteriophage mRNAs and proposed that this region,
`subsequently called the Shine-Dalgarno (SD) site, interacts
`with the complementary 3⬘ end of 16S rRNA during transla-
`tion initiation. This was confirmed by Steitz and Jakes (532).
`The spacing between the SD site and the initiating AUG codon
`can vary from 5 to 13 nucleotides, and it influences the effi-
`ciency of translational initiation (196). Extensive studies have
`been carried out to determine the optimal nucleotide sequence
`of the SD region, as well as the most effective spacing between
`the SD site and the start codon (28, 93, 131, 593). Ringquist et
`al. (458) examined the translational roles of the RBS and
`reached the following conclusions. (i) The SD sequence UAA
`GGAGG enables three- to sixfold-higher protein production
`than AAGGA for every spacing. (ii) For each SD sequence,
`there is an optimal although relatively broad spacing of 5 to 7
`nucleotides for AAGGA and 4 to 8 nucleotides for UAAGG
`AGG. (iii) For each SD sequence, there is a minimum spacing
`required for translation; for AAGGA, this minimum spacing is
`5 nucleotides, and for UAAGGAGG, it is 3 to 4 nucleotides.
`These spacings suggest that there is a precise physical relation-
`ship between the 3⬘ end of 16S rRNA and the anticodon of the
`fMe

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket